by Stu Steene-Connelly | Jul 3, 2024 | Patient Empowerment
When PrismRA can help guide treatment decisions: intended use & case study examples For patients with rheumatoid arthritis (RA), ineffective early treatment increases the likelihood of surgery, irreversible joint damage, and chronic pain.1 Prior to PrismRA,...
by Stu Steene-Connelly | May 15, 2024 | Patient Empowerment, Science & Technology
Examining the Clinical Utility of PrismRA PrismRA® is a blood-based precision medicine test used by over 1,400 advanced practitioners around the country to guide the treatment selection in their patients with rheumatoid arthritis. While validated precision medicine...